Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,512
Total Claims
$2.0M
Drug Cost
1,385
Beneficiaries
$1,426
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-22%
Opioid rate vs peers
1.8% vs 2.2% avg
+1%
Cost per patient vs peers
$1,426 vs $1,411 avg
+15%
Brand preference vs peers
12.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.8%
Opioid Rate
289
Opioid Claims
$5,479
Opioid Cost
3.8%
Long-Acting Rate
Brand vs Generic
Brand: 2,002 claims · $1.6M
Generic: 14,391 claims · $381K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 104 | $161K |
| Apixaban | 151 | $155K |
| Empagliflozin | 84 | $110K |
| Tirzepatide | 39 | $77K |
| Tofacitinib Citrate | 11 | $65K |
| Cariprazine Hcl | 39 | $65K |
| Rivaroxaban | 54 | $62K |
| Sitagliptin Phosphate | 49 | $61K |
| Dapagliflozin Propanediol | 36 | $55K |
| Mirabegron | 51 | $45K |
| Semaglutide | 17 | $39K |
| Fluticasone/Umeclidin/Vilanter | 40 | $39K |
| Linaclotide | 45 | $38K |
| Sitagliptin Phos/Metformin Hcl | 37 | $34K |
| Dulaglutide | 19 | $34K |
Prescribing Profile
Patient Profile
76
Avg Age
54%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About